3[10]Hou FF, Jiang JP, Guo JQ et al. Receptor for advanced glycation end products on human synovial fibroblasts: role in the pathogenesis of dialysis-related amyloidosis. J Am Soc Nephrol,2002,13(5):1296
4[11]Schmidt A M, Mora R, Cao R et al. The endothelial cell binding site for advanced glycation end products consists of a complex: an integral membrane protein and lactoferrin-like polypeptide. J Biol Chem,1994,269(13):9882
5[12]Owen WF Jr, Hou FF, Stuart RO et al. Beta 2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts. Kidney Int, 1998, 53(5):1365
6[13]Mercie P, Seigneur M, Bilhou-Nabera C et al. Nuclear transcription factor kappa B(NF- kappa B). Rev Med Interne ,1998,19:945
7[14]Griending KK, Sorescu D et al. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol, 2000,20(10):2175
8[1]Bucala R, Vlassara H. Advanced glycosylation end products in diabetic renal and vascular disease. Am J Kindney Dis,1995,26(6):875
9[2]Hou FF, Owen WF Jr. Beta 2-microglobulin amyloidosis: role of monocytes/macrophages. Curr Opin Nephrol Hypertens,2002, 11(4):417
10[3]Miyata T, Sugiyama S, Saito A et al. Reaction carbony1 compounds related uremic toxicity "carbony1 stress". Kidney Int, 2001, 78:S25
